Onco-Innovations Ltd. (TSE:ONCO)

NEO-L:ONCO

ONCO

Onco-Innovations Ltd.

RESEARCH TOOLSreports

Onco-Innovations Ltd. (ONCO) Price & Analysis

21 Followers

ONCO Stock Chart & Stats

C$1.47

C$0.03(2.80%)

At close: Jan 08 4:00 PM EST

C$1.47

C$0.03(2.80%)

Day’s Range― - ―

52-Week RangeC$1.45 - C$1.53

Previous CloseN/A

Volume353.06K

Average Volume (3M)47.16K

Market Cap

C$87.56M

Enterprise ValueN/A

Total Cash (Recent Filing)C$1.41M

Total Debt (Recent Filing)C$0.00

Price to Earnings (P/E)―

Beta0.66

Next Earnings

Aug 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.07

Shares Outstanding59,565,857

10 Day Avg. Volume42,021

30 Day Avg. Volume47,156

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Onco-Innovations Ltd. News

Onco-Innovations Sets Up Australian Subsidiary and Taps New Marketing Partner Ahead of Phase I Trials

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has issued an announcement. Onco-Innovations has executed an engagement agreement with RDI Partners...

2M ago

Onco-Innovations Raises $1.22 Million in Completed Private Placement

The latest update is out from Onco-Innovations Ltd. ( ($TSE:ONCO) ). Onco-Innovations Limited has closed a non-brokered private...

3M ago

Onco-Innovations Seeks Up to $2 Million in Private Placement to Advance Cancer Research

Onco-Innovations Ltd. ( ($TSE:ONCO) ) just unveiled an update. Onco-Innovations Limited plans to raise up to $2 million...

3M ago

Onco-Innovations Revises Pricing on $2 Million Private Placement

Onco-Innovations Ltd. ( ($TSE:ONCO) ) just unveiled an update. Onco-Innovations has amended the pricing of its previously announced...

4M ago

Onco-Innovations Files Preliminary Base Shelf Prospectus to Boost Financing Flexibility

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an announcement. Onco-Innovations Limited has filed a preliminary base shelf prospectus...

4M ago

Onco-Innovations Leads Precision Oncology Forum to Shape Future Cancer Care

The latest announcement is out from Onco-Innovations Ltd. ( ($TSE:ONCO) ). Onco-Innovations Limited, through its subsidiary Inka Health...

6M ago

Onco-Innovations Explores Nasdaq Cross-Listing and Equity Offering

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an announcement. Onco-Innovations Limited has engaged a U.S. investment bank to...

6M ago

Onco-Innovations Joins University of Alberta’s Innovation Awards, Advances Cancer Treatment Technology

An update from Onco-Innovations Ltd. ( ($TSE:ONCO) ) is now available. Onco-Innovations Limited attended the University of Alberta’s...

7M ago

Onco-Innovations Advances PNKP Inhibitor Technology with Dalton Pharma Services

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has shared an announcement. Onco-Innovations Limited has announced the advancement of its PNKP...

7M ago

Onco-Innovations Partners with Kuano to Enhance PNKP Inhibitor Development

Onco-Innovations Ltd. ( ($TSE:ONCO) ) has provided an update. Onco-Innovations Limited has announced a collaboration with Kuano Ltd....

7M ago

ONCO FAQ

What was Onco-Innovations Ltd.’s price range in the past 12 months?

Onco-Innovations Ltd. lowest stock price was C$1.45 and its highest was C$1.53 in the past 12 months.

What is Onco-Innovations Ltd.’s market cap?

Onco-Innovations Ltd.’s market cap is C$87.56M.

When is Onco-Innovations Ltd.’s upcoming earnings report date?

Onco-Innovations Ltd.’s upcoming earnings report date is Aug 05, 2026 which is in 56 days.

How were Onco-Innovations Ltd.’s earnings last quarter?

Onco-Innovations Ltd. released its earnings results on Apr 07, 2026. The company reported -C$0.053 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.053.

Is Onco-Innovations Ltd. overvalued?

According to Wall Street analysts Onco-Innovations Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Onco-Innovations Ltd. pay dividends?

Onco-Innovations Ltd. does not currently pay dividends.

What is Onco-Innovations Ltd.’s EPS estimate?

Onco-Innovations Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Onco-Innovations Ltd. have?

Onco-Innovations Ltd. has 59,565,857 shares outstanding.

What happened to Onco-Innovations Ltd.’s price movement after its last earnings report?

Onco-Innovations Ltd. reported an EPS of -C$0.053 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Onco-Innovations Ltd.?

Currently, no hedge funds are holding shares in TSE:ONCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Onco-Innovations Ltd. Stock Smart Score

Underperform

Insider Transactions

Sold Shares

Worth C$52.6K over
the Last 3 Months

Fundamentals

Return on Equity

-351.83%

Trailing 12-Months

Asset Growth

-61.62%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Onco-Innovations Ltd.

Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. Its product includes the ONC010 for cancer treatments. The company was founded on September 16, 2021 and is headquartered in Calgary, Canada.